title: Combined Benefits of a PAR2 Inhibitor and Stratum Corneum Acidification for Murine Atopic Dermatitis.
authors.affiliation: Department of Dermatology, Faculty of Medicine, Oita University, Oita, Japan.
authors.forename: Takashi
authors.initials: T
authors.lastname: Sakai
authors.affiliation: Department of Dermatology, Faculty of Medicine, Oita University, Oita, Japan. Electronic address: hatano@oita-u.ac.jp.
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Hatano
authors.affiliation: Department of Dermatology, Faculty of Medicine, Oita University, Oita, Japan.
authors.forename: Haruna
authors.initials: H
authors.lastname: Matsuda-Hirose
authors.affiliation: Department of Dermatology, Faculty of Medicine, Oita University, Oita, Japan.
authors.forename: Wei
authors.initials: W
authors.lastname: Zhang
authors.affiliation: Faculty of Medicine, Oita University, Oita, Japan.
authors.forename: Daisuke
authors.initials: D
authors.lastname: Takahashi
authors.affiliation: Division of Applied Research, NeoPharm Co., Ltd., Daejeon, South Korea.
authors.forename: Se Kyoo
authors.initials: SK
authors.lastname: Jeong
authors.affiliation: Dermatology Service, Veterans Affairs Medical Center, San Francisco, California, USA; Department of Dermatology, University of California, San Francisco, California, USA.
authors.forename: Peter M
authors.initials: PM
authors.lastname: Elias
authors.affiliation: Department of Dermatology, Faculty of Medicine, Oita University, Oita, Japan.
authors.forename: Sakuhei
authors.initials: S
authors.lastname: Fujiwara
mesh_terms: D000818:Animals; D003876:Dermatitis, Atopic / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology*; D004187:Disaccharides / Q000494:pharmacology*; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D004817:Epidermis / Q000187:drug effects; D007136:Immunoglobulins / Q000378:metabolism; D051379:Mice; D008815:Mice, Inbred Strains; D010081:Oxazolone / Q000494:pharmacology; D011897:Random Allocation; D044464:Receptor, PAR-2 / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D018121:Receptors, Cytokine / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D004187:Disaccharides; D007136:Immunoglobulins; D044464:Receptor, PAR-2; D018121:Receptors, Cytokine; C410591:Tslpr protein, mouse; D010081:Oxazolone; C005608:lactobionic acid